Effect on insulin sensitivity of Implanon vs. GnRH agonist in women with endometriosis

Contraception

Volumn 72, Issue 6, 2005, Pages 443-446

  Cagnacci, Angelo ^a,b   Tirelli, Alessandra ^a   Cannoletta, Marianna ^a   Pirillo, Debora ^a   Volpe, Annibale ^a  

^a UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^b UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

Author keywords

Desogestrel; Endometriosis; Etonogestrel; GnRH agonist; Implanon; Insulin sensitivity

Indexed keywords

C PEPTIDE; ETONOGESTREL; GLUCOSE; GONADORELIN AGONIST; INSULIN; LEUPRORELIN;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ENDOMETRIOSIS; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; GLUCOSE UTILIZATION; HUMAN; INSULIN SENSITIVITY; INTRAVENOUS GLUCOSE TOLERANCE TEST; LONG TERM CARE; RANDOMIZED CONTROLLED TRIAL; STATISTICAL SIGNIFICANCE;

BLOOD GLUCOSE; C-PEPTIDE; DESOGESTREL; DRUG IMPLANTS; ENDOMETRIOSIS; FASTING; FEMALE; GLUCOSE TOLERANCE TEST; HUMANS; INSULIN; INSULIN RESISTANCE; LEUPROLIDE;

EID: 27944438465     PISSN: 00107824     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.contraception.2005.05.021     Document Type: Article

References (31)

1. G.M. Reaven Role of insulin resistance in human disease (syndrome X): an expanded definition Annu Rev Med 44 1993 121 131
2. K.R. Petersen, E. Christiansen, S. Madsbad, S.O. Skouby, L.F. Andresen, and J. Jespersen Metabolic and fibrinolytic response to changed insulin sensitivity in users of oral contraceptives Contraception 60 2000 337 344
3. H.C. Grestein, and S. Yususf Dysglycaemia and risk of cardiovascular disease Lancet 347 1996 949 950
4. H. Gerlach, C. Esposito, and D.M. Stern Modulation of endothelial hemostatic properties: an active role in the host response Annu Rev Med 41 1990 15 24
5. R. Stout Insulin and atheroma Diabetes Care 13 1990 572 576
6. C. Ferri, V. Pittoni, and A. Piccoli Insulin stimulates endothelin-1 secretion from human endothelial cells and modulates its circulating levels in vivo J Clin Endocrinol Metab 80 1995 829 835
7. C. Walton, I.F. Godsland, A.J. Proudler, V. Wynn, and J.C. Stevenson The effects of the menopause on insulin sensitivity, secretion and elimination in non-obese, healthy women Eur J Clin Invest 23 1993 466 473
8. A.J. Proudler, C.V. Felton, and J.C. Steventson Ageing and the response of plasma insulin, glucose, and C-peptide concentrations to intravenous glucose in postmenopausal women Clin Sci 83 1992 489 494
9. I. Godsland, D. Crook, and V. Wynn Oral contraceptive estrogen content and carbohydrate and lipid metabolic risk markers for coronary heart disease J. Newton M. op ten Berg Optimizing the estrogen dose in oral contraceptives 1992 Parthenon Canforth 39 50
10. I.F. Godsland Effects on carbohydrate metabolism I.S. Fraser R.P.S. Jansen R.A. Lobo M.I. Whitehead Estrogens and progestogens in clinical practice 1998 Churchill Livingstone London 773 785
11. U.J. Gaspard, F. Demeyer, C.B. Jaminet, A.J. Scheen, and P.J. Lefebvre Influence of two low dose oral contraceptives containing ethinylestradiol (20 μg) and desogestrel or gestodene on carbohydrate metabolism during 1 year of use Gynecol Endocrinol 10 Suppl 1996 179 181
12. J. Donnez Today's treatments: medical, surgical and in partnership Int J Obstet Gynecol 64 1999 5 13
13. The American Fertility Society Revised American Fertility Society classification of endometriosis: 1985 Fertil Steril 43 1985 351 352
14. A. Cagnacci, S. Arangino, A. Renzi, P. Cagnacci, and A. Volpe Insulin sensitivity in women: a comparison among values derived from intravenous glucose tolerance tests with different sampling frequency, oral glucose tolerance test or fasting Eur J Endocrinol 145 2001 281 287
15. A. Cagnacci, R. Soldani, P.L. Carriero, A.M. Paoletti, P. Fioretti, and G.B. Melis Effect of low doses of transdermal 17β-estradiol on carbohydrate metabolism in postmenopausal women J Clin Endocrinol Metab 74 1992 1396 1400
16. A. Cagnacci, F. Tuveri, R. Cirillo, A.M. Setteneri, G.B. Melis, and A. Volpe The effect of 17β-estradiol on glucose metabolism of postmenopausal women is evident during the oral but not the intravenous glucose administration Maturitas 28 1998 163 167
17. R.W. Shaw An open randomized comparative study of the effect of goserelin depot and danazol in the treatment of endometriosis. Zoladex endometriosis study team Fertil Steril 58 1992 265 272
18. P. Vercellini, L. Trepidi, A. Colombo, N. Vendola, M. Marchini, and P.G. Crosignani A gonadropin-releasing hormone agonist versus a low-dose oral contraceptive for pelvic pain associated with endometriosis Fertil Steril 60 1993 75 79
19. P. Vercellini, I. Cortesi, and P.G. Crosignani Progestins for symptomatic endometriosis: a critical analysis Fertil Steril 68 1997 393 401
20. H.J. Bennik The pharmacokinetics and pharmacodynamics of Implanon, a single-rod etonogestrel contraceptive implant Eur J Contracept Reprod Health Care 5 2000 12 20
21. American Diabetes Association Consensus Development Conference on Insulin Resistance; 5-6 November 1997 Diabetes Care 21 1998 310 314
22. A. Cagnacci, A.M. Paoletti, S. Arangino, G.B. Melis, and A. Volpe Effect of ovarian suppression on glucose metabolism of young lean women with and without ovarian hyperandrogenism Hum Reprod 14 1999 893 897
23. I.M. Golland, C.A. Vaughan-Williams, S.M. Shalet, I. Laing, and M. Elstein Influence of danazol and goserelin on insulin and glucagon in non-obese women with endometriosis Acta Endocrinol 123 1990 405 410
24. S. Palomba, T. Russo, and F. Orio Lipid, glucose and homocysteine metabolism in women treated with a GnRH agonist with or without raloxifene Hum Reprod 19 2004 415 421
25. F. Abassi, and G.M. Reaven Evaluation of the quantitative insulin sensitivity check index as an estimate of insulin sensitivity in humans Metabolism 52 2002 235 237
26. A. Biswas, O.A.C. Viegas, H.J.T.C. Bennink, T. Korver, and S.S. Ratnam Implanon contraceptive implants: effects on carbohydrate metabolism Contraception 63 2001 137 141
27. J.C. Konje, O. Odukuya, E. Otolorin, P. Ewing, and O.A. Ladipo Carbohydrate metabolism before and after Norplant removal Contraception 46 1992 61 69
28. J.C. Konje, E.O. Otolorin, and O.A. Ladipo The effect of continuous subdermal levonorgestrel (Norplant) on carbohydrate metabolism Am J Obstet Gynecol 166 1992 15 19
29. K. Singh, O.A.C. Viegas, and S.S. Ratnam Effect of Norplant implants on liver, lipid and carbohydrate metabolism Contraception 45 1992 141 153
30. T.B. Koopersmith, and R.A. Lobo Insulin sensitivity is unaltered by the use of the Norplant subdermal implant contraceptive Contraception 51 1995 197 200
31. I. Barbosa, E. Countinho, C. Athayde, O. Ladipo, S.E. Olsson, and U. Ulmsten The effects of nomegestrol acetate subdermal implant (Uniplant) on carbohydrate metabolism, serum lipoproteins and on hepatic function in women Contraception 52 1995 111 114